Reason: Presence of Particulate Matter: Customer complaint of dark particles found inside the vial
Distributed: Nationwide in the USAReason: Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.
Distributed: USA NationwideReason: CGMP Deviations: Impurities of acetal and acetaldehyde were discovered in the product in excess of allowed limits.
Distributed: Nationwide in United States and Canada.Reason: Failed impurities/degradation specifications: Out of specification for unknown impurities.
Distributed: USA NationwideReason: Labeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg.
Distributed: USA NationwideReason: CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
Distributed: Product was distributed by major distribution chains nationwide.Reason: CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
Distributed: Product was distributed by major distribution chains nationwide.Reason: Failed Impurities/Degradation Specifications
Distributed: Nationwide in the USA and Puerto Rico.Reason: Presence of foreign substance
Distributed: Nationwide within the United StatesReason: Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content
Distributed: USA Nationwide